Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment-Reference-Cited by-同舟云学术

Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment

Published:2015-11-04 Issue:11 Volume:90 Page:2763-2777
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Chaudhari Umesh,Nemade Harshal,Wagh Vilas,Gaspar John Antonydas,Ellis James K.,Srinivasan Sureshkumar Perumal,Spitkovski Dimitry,Nguemo Filomain,Louisse Jochem,Bremer Susanne,Hescheler Jürgen,Keun Hector C.,Hengstler Jan G.,Sachinidis Agapios

Funder

Directorate-General for Health and Consumers (BE)

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00204-015-1623-5.pdf

Reference52 articles.

1. Akhmedov AT, Rybin V, Marin-Garcia J (2015) Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart. Heart Fail Rev 20:227–249

2. Anson BD, Kolaja KL, Kamp TJ (2011) Opportunities for use of human iPS cells in predictive toxicology. Clin Pharmacol Ther 89:754–758

3. Appel JM, Nielsen D, Zerahn B, Jensen BV, Skagen K (2007) Anthracycline-induced chronic cardiotoxicity and heart failure. Acta Oncol 46:576–580